Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ACOD1 as a Prognostic Marker for Sepsis — Stella

Home/Sepsis/ACOD1 as a Prognostic Marker for Sepsis

View on ClinicalTrials.gov

Recruiting

Back to Sepsis trials

ACOD1 as a Prognostic Marker for Sepsis

Trial locations(2 sites)

China

Department of Critical Care Medicine, Union Hospital, Tongji Medical College,Huazhong University of Science and Technology, Wuhan, Wuhan, Hubei

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei

Key details

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Enrollment target

~52 participants

Started

October 2025

Primary completion

June 2026

Age range

18 Years – 90 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.